<code id='601D7CCECE'></code><style id='601D7CCECE'></style>
    • <acronym id='601D7CCECE'></acronym>
      <center id='601D7CCECE'><center id='601D7CCECE'><tfoot id='601D7CCECE'></tfoot></center><abbr id='601D7CCECE'><dir id='601D7CCECE'><tfoot id='601D7CCECE'></tfoot><noframes id='601D7CCECE'>

    • <optgroup id='601D7CCECE'><strike id='601D7CCECE'><sup id='601D7CCECE'></sup></strike><code id='601D7CCECE'></code></optgroup>
        1. <b id='601D7CCECE'><label id='601D7CCECE'><select id='601D7CCECE'><dt id='601D7CCECE'><span id='601D7CCECE'></span></dt></select></label></b><u id='601D7CCECE'></u>
          <i id='601D7CCECE'><strike id='601D7CCECE'><tt id='601D7CCECE'><pre id='601D7CCECE'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:13718
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          With psoriasis trial ahead, Alumis raises $259 million
          With psoriasis trial ahead, Alumis raises $259 million

          Aclose-upofpsoriasisonahand.AdobeSanFranciscostartupAlumisInc.hasraised$259millioninabidtobestbigpha

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

          SammyKimballforSTATAredrugpricesprotectedbytheConstitution?WillMedicareembraceAlzheimer’sdiseasetrea